Drug Trial Radar · NCT04593459
Probiotic Intervention in PCOS
Last checked: Nov 20, 2026Latest source record: Mar 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
112
Actual
Start
Nov 3, 2020
Primary completion
Oct 16, 2023
Study completion Oct 16, 2023
Sponsor
- Lead sponsor
- Medical University of GrazAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Institut AllergoSan Pharma GmbH; Winclove Probiotics B.V.
- First posted
- Oct 20, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators are conducting a double-blinded randomized controlled trial to determine whether a probiotic mixture is effective in reducing PCOS-related symptoms. For this purpose, 180 participants will be recruited in three intervention arms (Probiotic, Placebo and Metformin), with 60 participants per arm. The intervention period will last 6 months, with extensive medical history, blood work, urine and stool analysis at the beginning and the conclusion of the trial.
Conditions
- Polycystic Ovary Syndrome
Interventions
ProbioticDietary supplement
See Arm description
Metformin HydrochlorideDrug
See Arm description
Probiotic PlaceboDietary supplement
See Arm description
Primary outcomes
What the sponsor says the trial is designed to measure.
- Free testosteroneTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical University of Graz, Division of Endocrinology and Diabetology
Graz, Styria, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.